Company Filing History:
5 out of 416 
2 out of 52,711 
2 out of 11 Years Active: 2012-2025
Title: Toshiro Sakai: Innovator in Pharmaceutical Composition
Introduction
Toshiro Sakai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the solubility and absorbability of key compounds.
Latest Patents
Sakai holds a total of six patents, with his latest innovations focusing on pharmaceutical compositions for oral administration. One notable patent involves a formulation that improves the solubility and dissolution properties of enzalutamide, a drug used in cancer treatment. This composition not only enhances the solubility but also maintains supersaturation, thereby improving oral absorbability. Another significant patent details various formulations of enzalutamide aimed at treating hyperproliferative disorders.
Career Highlights
Throughout his career, Toshiro Sakai has worked with leading companies in the pharmaceutical industry, including Astellas Pharma GmbH and Kabushiki Kaisha Toshiba. His work has been instrumental in advancing drug formulations that benefit patients and improve treatment outcomes.
Collaborations
Sakai has collaborated with notable professionals in his field, including Takanari Inatomi and Toshiyuki Suzuki. These partnerships have fostered innovation and have contributed to the successful development of his patented formulations.
Conclusion
Toshiro Sakai's contributions to pharmaceutical compositions demonstrate his commitment to improving drug efficacy and
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.